Furthermore, the Company notes, that despite the increase in share price over recent days, the current share price still represents a substantial discount
Vortex Vortex's technology is ready to be adopted by large pharmaceutical players to improve how oncology treatment is determined." NetScientific holds 66.1% of Vortex Biosciences on a fully diluted basis.
Wanda App service being taken up by Medical Services.